Primer: Venus MedTech (2500 HK) - Apr 2026
Venus MedTech is a leading Chinese domestic player in the transcatheter structural heart valvular therapy market, with a comprehensive product...
163 Views
𝛼SK or SearchENTITY
Venus Medtech (Hangzhou) (2500 HK)
Venus Medtech (Hangzhou) (2500 HK)
111
Analysis
Health Care • China
Venus Medtech is a leading medical device company specializing in transcatheter structural heart valvular therapies. It develops and commercializes innovative solutions for all four heart valves (TAVR, TPVR, TMVR, TTVR) and interventional hypertension treatment. The company was founded in 2009 and is headquartered in Hangzhou, China.
morex